|
Video: What is a Stock Split?
|
|
Oncocyte is a precision diagnostics company focused on developing and commercializing proprietary tests in three areas: DetermaIO is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies, VitaGraft is a blood-based solid organ transplantation monitoring test and DetermaCNI is a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients. According to our OCX split history records, Oncocyte has had 1 split. | |
|
Oncocyte (OCX) has 1 split in our OCX split history database. The split for OCX took place on July 25, 2023. This was a 1 for 20 reverse split, meaning for each 20 shares of OCX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.
When a company such as Oncocyte conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the OCX split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Oncocyte shares, starting with a $10,000 purchase of OCX, presented on a split-history-adjusted basis factoring in the complete OCX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
01/05/2016 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$202.20 |
|
End price/share: |
$2.93 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.55% |
|
Average Annual Total Return: |
-40.22% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$144.89 |
|
Years: |
8.23 |
|
|
|
Date |
Ratio |
07/25/2023 | 1 for 20 |
|
|